Evaluation of the Maryland Health Home Program for Medicaid Enrollees with Severe Mental Illnesses or Opioid Substance Use Disorder and Risk of Additional Chronic Conditions

Thumbnail Image

Files

HealthHomesProgram-ARM-June2018.pdf (538.4 KB)

Links to Files

https://www.hilltopinstitute.org/publication/evaluation-of-the-maryland-health-home-program-for-medicaid-enrollees-with-severe-mental-illnesses-or-opioid-substance-use-disorder-and-risk-of-additional-chronic-conditions/

Permanent Link

http://hdl.handle.net/11603/12890

Collections

A. All Hilltop Institute (UMBC) Works
UMBC Faculty Collection
UMBC Staff Collection

Author/Creator

Author/Creator ORCID

Date

2018-06-25

Type of Work

presentations (communicative events)
Text

Department

Program

Citation of Original Publication

Rights

This item is likely protected under Title 17 of the U.S. Copyright Law. Unless on a Creative Commons license, for uses protected by Copyright Law, contact the copyright holder or the author.

Subjects

Maryland Health Home Program
integrated somatic and behavioral health services
serious and persistent mental illness (SPMI)
Medicain enrollees with an opioid Substance Use Disorder (SUD)
Medicain enrollees at risk of chronic conditions
study group and comparison group evaluation

Abstract

Hilltop staff presented at the 2018 AcademyHealth Annual Research Meeting (ARM) in Seattle in June. Senior Policy Analyst Shamis Mohamoud, MA, gave this podium presentation, which provided an overview of Hilltop’s evaluation of the Maryland Health Home Program